Mark S. Ordan net worth and biography

Mark Ordan Biography and Net Worth

Mark Ordan joined Mednax in July 2020 and currently serves as Chief Executive Officer. Previously, Mr. Ordan founded and served as Chief Executive Officer of Quality Care Properties, Inc. from 2016 to 2018. In July 2018, he completed a sale of the company to Welltower and Promedica. Before that, Mr. Ordan served as Chief Executive Officer of Washington Prime Group Inc. from 2014 to 2015, from its inception as a spin-off of the Simon Property Group. From 2008 to 2013, Mr. Ordan served as Chief Executive Officer of Sunrise Senior Living, Inc. where he led the company’s turnaround and restructuring and oversaw the sale of the company in January 2013.  From 2006 to 2007, he served as Chief Executive Officer of The Mills Corporation, which he sold to Simon Property Group and Farrallon.

Mr. Ordan holds a bachelor’s degree in philosophy from Vassar College. He received a master’s degree in business administration from Harvard Business School. Additionally, he is a recipient of the Hitchcock Humanitarian Award from the Cystic Fibrosis Foundation and is an inductee of the Washington Business Hall of Fame.

Mr. Ordan currently serves on the Board of Directors of Mednax, Federal Realty Investment Trust and Vassar College. Additionally, he serves as Vice Chairman of the Board for the U.S. Chamber of Commerce.

What is Mark S. Ordan's net worth?

The estimated net worth of Mark S. Ordan is at least $5.43 million as of November 21st, 2022. Mr. Ordan owns 346,645 shares of Pediatrix Medical Group stock worth more than $5,431,927 as of December 6th. This net worth approximation does not reflect any other assets that Mr. Ordan may own. Additionally, Mr. Ordan receives a salary of $3,350,000.00 as CEO at Pediatrix Medical Group. Learn More about Mark S. Ordan's net worth.

How old is Mark S. Ordan?

Mr. Ordan is currently 63 years old. There are 4 older executives and no younger executives at Pediatrix Medical Group. Learn More on Mark S. Ordan's age.

What is Mark S. Ordan's salary?

As the CEO of Pediatrix Medical Group, Inc., Mr. Ordan earned a total compensation package of $6,848,969.00 in 2021. Mr. Ordan earned a salary of $1,000,000.00, stock awards of $3,500,021.00, non-equity compensation of $2,340,000.00, and other compensation of $8,948.00. Learn More on Mark S. Ordan's salary.

How do I contact Mark S. Ordan?

The corporate mailing address for Mr. Ordan and other Pediatrix Medical Group executives is 1301 CONCORD TERRACE, SUNRISE FL, 33323. Pediatrix Medical Group can also be reached via phone at (954) 384-0175 and via email at [email protected] Learn More on Mark S. Ordan's contact information.

Has Mark S. Ordan been buying or selling shares of Pediatrix Medical Group?

Within the last three months, Mark S. Ordan has sold $342,464.70 in shares of Pediatrix Medical Group stock. Most recently, Mark S. Ordan sold 22,166 shares of the business's stock in a transaction on Monday, November 21st. The shares were sold at an average price of $15.45, for a transaction totalling $342,464.70. Following the completion of the sale, the chief executive officer now directly owns 346,645 shares of the company's stock, valued at $5,355,665.25. Learn More on Mark S. Ordan's trading history.

Who are Pediatrix Medical Group's active insiders?

Pediatrix Medical Group's insider roster includes Roger Hinson (Insider), Roger Medel, M.D. (Director), Mark Ordan (CEO), and John Pepia (Insider). Learn More on Pediatrix Medical Group's active insiders.

Are insiders buying or selling shares of Pediatrix Medical Group?

In the last twelve months, insiders at the sold shares 5 times. They sold a total of 261,288 shares worth more than $6,821,151.41. The most recent insider tranaction occured on November, 21st when CEO Mark S Ordan sold 22,166 shares worth more than $342,464.70. Insiders at Pediatrix Medical Group own 3.4 % of the company. Learn More about insider trades at Pediatrix Medical Group.

Information on this page was last updated on 11/21/2022.

Mark S. Ordan Insider Trading History at Pediatrix Medical Group

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/21/2022Sell22,166$15.45$342,464.70346,645View SEC Filing Icon  
8/30/2021Sell95,000$35.09$3,333,550.00View SEC Filing Icon  
See Full Table

Mark S. Ordan Buying and Selling Activity at Pediatrix Medical Group

This chart shows Mark S Ordan's buying and selling at Pediatrix Medical Group by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Pediatrix Medical Group Company Overview

Pediatrix Medical Group logo
Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States and Puerto Rico. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians, including maternal-fetal nurse practitioners, certified nurse mid-wives, ultrasonographers, and genetic counselors. In addition, it offers pediatric cardiology care services comprising inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patient with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through affiliated pediatric cardiologist subspecialists and other related clinical professionals; and specialized cardiac care to the fetus, neonatal and pediatric patients. Further, the company provides other pediatric subspecialty care services through pediatric subspecialists, such as pediatric intensivists, pediatric hospitalists, pediatric surgeons, and pediatric ophthalmologists, as well as pediatric ear, nose, and throat physicians; and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. As of February 17, 2022, it operated a network of approximately 2,700 physicians. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.
Read More

Today's Range

Now: $15.32
Low: $15.32
High: $15.81

50 Day Range

MA: $16.77
Low: $14.92
High: $19.54

2 Week Range

Now: $15.32
Low: $14.48
High: $28.02

Volume

14,562 shs

Average Volume

475,864 shs

Market Capitalization

$1.27 billion

P/E Ratio

15.47

Dividend Yield

N/A

Beta

1.74
Potential Gold Rush For Investors Sparked By USA Vs. China Trade War
Right now, China has the US Military in a stranglehold. They hold a monopoly on one of our most CRITICAL defense elements. But thanks to executive orders from both Biden and Trump...
China's Monopoly Is About To Crumble...